Our Team

Kriya Therapeutics GMP Ribbon Cutting Event Morrisville, NC 07-22-2021

Our leadership team is comprised of leading scientists, operators and entrepreneurs.

Leadership

  • Wayne Yount, PhD

    Senior Vice President, Analytical & Formulation Sciences & Quality Control

  • Shankar Ramaswamy, MD

    Co-Founder, Chairman and CEO

  • Nachi Gupta, MD, PhD

    Chief Innovation Officer

  • Mitch Lower

    Senior Vice President, Technical Operations

  • Michele Stone, PhD

    Chief Scientific Officer

  • Lily Wan

    Senior Vice President, Strategic Planning and Integration

  • Joseph Rabinowitz, PhD

    Senior Vice President, Novel Technologies

  • Jennifer Coggburn

    Vice President, People Operations

  • Erik Hughes, PhD

    Senior Vice President, Technical Development

  • Dana B. Johnson

    Chief Legal Officer & Corporate Secretary

  • Curt Herberts, MBS

    President & Chief Operating Officer

  • Britt Petty

    Chief Manufacturing Officer

  • Brian Furmanski, PhD

    Chief Regulatory Officer

  • Ashlyn Bassiri, PhD

    Senior Vice President, Nonclinical Safety, Immunology and Bio Analytics

Board of Directors

  • Shankar Ramaswamy, MD

    Co-Founder, Chairman and CEO

  • Roger Jeffs, PhD

    Co-Founder and Vice Chairman

  • Neel Varshney, MD

    Director

  • Ilan Oren

    Director

  • Saira Ramasastry

    Director

  • Keith Manchester, MD

    Director

  • Jim Momtazee

    Director

  • Trit Garg Headshot

    Trit Garg, MD

    Director

  • Ryan-Gallagher

    Ryan Gallagher, PhD

    Director

Scientific and Strategic Advisors

  • Sincock_CR-final

    C.R. Sincock, II

    Founding Investor and Senior Strategic Advisor

  • Fraser Wright, PhD

    Scientific Co-Founder and Chief Technology Advisor

  • Guangping Gao, PhD

    Scientific Advisory Board Member

  • Mark-Kay-final

    Mark A. Kay, MD, PhD

    Scientific Advisory Board Member

  • Fátima Bosch, PhD

    Scientific Advisory Board Member

  • Fulvio Mavilio, PhD

    Scientific Advisory Board Member

  • Brenda Cooperstone, MD

    Chief Development Advisor